E
Bicycle Therapeutics plc BCYC
$9.69 $0.060.62%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Revenue -30.44% -50.00% -17.86% 298.90% 67.38%
Total Other Revenue -- -- -- -- --
Total Revenue -30.44% -50.00% -17.86% 298.90% 67.38%
Cost of Revenue -218.89% 19.59% 3.11% 9.73% 80.08%
Gross Profit 248.90% -30.94% -12.40% 46.61% -81.69%
SG&A Expenses 81.96% 16.11% 1.98% 9.75% 20.32%
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 19.82% 18.47% 2.75% 9.74% 68.28%
Operating Income -24.76% -25.69% -8.20% 24.13% -68.37%
Income Before Tax -8.52% -13.91% 7.94% 32.18% -60.47%
Income Tax Expenses -438.13% -251.76% 122.24% 43.37% 176.19%
Earnings from Continuing Operations -5.61% -1.81% 6.55% 32.00% -63.78%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -5.61% -1.81% 6.55% 32.00% -63.78%
EBIT -24.76% -25.69% -8.20% 24.13% -68.37%
EBITDA -25.44% -25.59% -8.54% 25.31% -70.58%
EPS Basic 35.13% 41.59% 45.74% 52.07% -14.72%
Normalized Basic EPS 27.70% 35.81% 46.54% 52.20% -12.40%
EPS Diluted 35.13% 41.59% 45.74% 52.07% -14.72%
Normalized Diluted EPS 27.70% 35.81% 46.54% 52.20% -12.40%
Average Basic Shares Outstanding 62.78% 74.32% 72.21% 41.86% 42.77%
Average Diluted Shares Outstanding 62.78% 74.32% 72.21% 41.86% 42.77%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --
Weiss Ratings